Background/Aims: Retinitis pigmentosa (RP) is characterized by degeneration of photoreceptors, and there are currently no effective treatments for this disease. However, curcumin has shown neuroprotectant efficacy in a RP rat and swine model, and thus, may have neuroprotective effects in this disease. Methods: Immunofluorescence staining, electroretinogram recordings, and behavioral tests were used to analyze the effects of curcumin and the underlying mechanism in retinal degeneration 1 (rd1) mice. Results: The number of apoptotic cells in the retina of rd1 mice at postnatal day 14 significantly decreased with curcumin treatment and visual function was improved. The activation of microglia and secretion of chemokines and matrix metalloproteinases in the retina were inhibited by curcumin. These effects were also observed in a co-culture of BV2 microglial cells and retinaderived 661W cells. Conclusions: Curcumin delayed retinal degeneration by suppressing microglia activation in the retina of rd1 mice. Thus, it may be an effective treatment for neurodegenerative disorders such as RP.
Introduction
As one of the main causes of blindness, retinitis pigmentosa (RP) is characterized by the degeneration and apoptosis of photoreceptors and retinal pigment epithelium [1] . As of May 23, 2017, more than 67 genes had been identified as pathogenic genes of RP (RetNet, http:// www.sph.uth.tmc.edu/RetNet/). However, to date, there are no effective treatments for this disease.
Intravitreal injections
In rd1 mice, intravitreal injection of curcumin (Sigma Aldrich, St. Louis, MO, USA) was performed in one eye, while the contralateral eye was injected with DMSO (Sigma Aldrich, St. Louis, MO, USA) to serve as control. Using the same procedure, dimethyl sulphoxide (DMSO) was intravitreally injected as a control. C57 mice were used as controls and treated in the same way. Mice at P7 were anesthetized by intraperitoneal injection of 1% pelltobarbitalum natricum (10 µL) . After a drop of topical anesthetic agent (oxybuprocaine) was administered, DMSO or curcumin (10 µM/L dissolved in DMSO) [31] was injected into the vitreous humor with a syringe (33G; Hamilton, Bonaduz, Switzerland). Unless otherwise indicated, intravitreal injections were performed in a final volume of 1 µL [30, 32] .
Immunofluorescence staining and terminal deoxynucleotidyl transferase UTP nick end labelling assay
Immunofluorescence staining and terminal deoxynucleotidyl transferase UTP nick end labelling (TUNEL) assay of frozen tissue sections and cell slides were performed as previously described [33, 34] . Briefly, for frozen tissue sections, the eyeballs of the mice were enucleated and fixed in 4% paraformaldehyde at room temperature (RT) for 2 h. Meanwhile, the anterior segments were removed under a microscope (Olympus, Tokyo, Japan). Then the eyeballs were infiltrated with 30% sucrose overnight at 4°C. Before cutting into a 10 µm thick sagittal slice by a freezing microtome (Thermo Fisher, Waltham, MA, USA), the retinas were embedded in optimal cutting temperature solution (Sakura Finetek, Torrance, CA, USA) for long-term storage at -80°C. For slides, the cells were fixed in 4% paraformaldehyde at RT for 30 min. Then, both the cells and the sections were incubated in 0.3% Triton X-100 for 10 min and 5% goat serum for 30 min at RT. For immunofluorescence staining, the sections were incubated with anti-ionized calcium binding adaptor molecule 1 (iba1) (1:750; Wako, Tokyo, Japan) and the cells were incubated with anti-ki67 antibody (1:500; Abcam, Cambridge, UK) or anti-caspase-3 antibody (1:400; Cell Signaling Technology, Danvers, MA, USA) at 4°C overnight, followed by incubation with Alexa Fluor488 (Molecular Probes, Life technologies, Eugene, OR, USA) for 2 h at 37°C. For the TUNEL assay, the sections were incubated with buffers 1 and 2 (In Situ Cell Death Detection Kit, Roche, Basel, Switzerland), mixed at a 1:9 ratio, for 2 h at 37°C according to the manufacturer's instructions. The cell nuclei were counterstained with 40, 6-diamidino-2-phenylindole (DAPI; Sigma Aldrich, St. Louis, MO, USA) after washing with phosphate-buffered saline. All staining was visualized and quantified using a ZEISS LSM800 confocal microscope (ZEN Microsystems; ZEISS, Germany).
ERG
The ERG procedures were performed as previously described [35] . In brief, mice at P18 (n=5 for each time point) were adapted to darkness for at least 8 h, and each recording procedure was done under dim red light. After anesthesia with 1% pelltobarbitalum natricum (0.06 mL), mice were kept warm on a heating pad and maintained at 37°C. Pupils were dilated with tropicamide eye drops (Santen Pharmaceutical, Osaka, Japan). Recording electrodes were placed at the cornea, reference electrodes were inserted under the skin of the angulus oculi, and grounding electrodes were inserted in the tail. Single flash recordings were gained at a 0.5 log 10 (cd s/m 2 ) light and acquired with a retinal scan system (Roland Consult, Havel, Germany).
Light/dark transition test
The light/dark transition test was performed as previously described [36] . The light/dark box (240 mm × 130 mm × 130 mm) consisted of a light chamber (160 mm × 130 mm × 130 mm) and a dark chamber (80 mm × 80 mm × 80 mm) connected with a 30 mm × 25 mm door in the middle (Fig. 3A) [37, 38] . The mice were dark-adapted for at least 8 h and stayed in a cage alone for 2 min before the test without any light stimulus. After the habituation period, the mice were allowed to explore both chambers for 5 min. The test field was lit at 300 lux by a tungsten filament bulb positioned over the center of the light chamber. All mice were tested alone (only one test per mouse). After each test, the box was cleaned with alcohol. qPCR qPCR was carried out as previously described [39] . In brief, total RNA of each retina was extracted with 1 mL TRIzol Reagent (Sigma), 200 µL chloroform, 500 µL isopropanol, and 1 mL 75% ethyl alcohol. Then the purity and concentration of the RNA were measured with a spectrophotometric instrument (Thermo Fisher). According to the manufacturer's instructions, the PrimeScript RT Reagent Kit (Takara, Tokyo, Japan) was used to carry out reverse transcription, and a SYBR Green qPCR Mix (Dongsheng Biotech, Guangzhou, Guangdong, China) was used to perform qPCR with a CFX96 Real-Time PCR System (Bio-Rad, Hercules, CA, USA). The primers were provided by Sangon Biotech (Shanghai, China) and the sequences are shown in Table 1 . The PCR conditions were as follows: 30 s at 95°C, 41 cycles of 5 s at 95°C, 30 s at 60°C followed by plate reading and then 10 s at 95°C followed by melting curve analysis (65-95°C, increments of 0.5°C per 5 s).
Co-culture and treatment of BV2 and 661W cells
The 661W cells were kindly gifted by Dr. Luo of State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China [40] , and the BV2 cells were provided by Dr. Guo of the Neurological Surgery Department of Southwest Hospital [30] . Cell culture was performed as previously described [16, 30] . Both cell types were cultured on 60 mm dishes at 37°C in a humidified atmosphere containing 5% CO 2 with Dulbecco's Modified Eagle's Medium (DMEM; Hyclone, GE Healthcare Life Sciences, Pittsburgh, PA, USA) containing 10% fetal bovine serum (FBS, PAN Biotech, Aidenbach, Germany) and 1% penicillin-streptomycin (Thermo Fisher). In the following assays, the BV2 cells were seeded into 6-well plates at a concentration of 5×10 4 cells per well. After 17 h, the cells were divided into six groups: (A) control; (B) DMSO; (C) curcumin (20 µM/L); (D) lipopolysaccharide (LPS); (E) LPS+curcumin (10 µM/L); and (F) LPS+curcumin (20 µM/L). Here, LPS was used as a stimulator, as it can cause an increase in the proliferation of BV2 cells [41, 42] . Different concentrations of curcumin were added to groups C, E, and F, and after 3 h, the media was refreshed and LPS (1 µg/mL) was added to groups D, E, and F. Then, after 4 h, the media was refreshed in each group and the cells were cultured for another 24 h, after which the cells were collected for subsequent experiments.
Transwell assay with hydrogen peroxide and curcumin
The transwell co-culture system was designed as shown in Fig. 7A and 7B. The 661W cells were seeded into 24-well plates at a concentration of 1×10 4 cells per well, and the BV2 cells were seeded on the transwell (Merck Millipore, Germany) at a concentration of 2×10 3 cells per well, and separately cultured. After 21 h, the cells were divided into three groups: control; hydrogen peroxide (H 2 O 2 ), which was used to stimulate apoptosis [16] ; and H 2 O 2 + curcumin. Then, 20 µM/L curcumin was added to BV2 cells of the H 2 O 2 + curcumin group. After 2.5 h, 1 mM/L H 2 O 2 was added to the 661W cells in the H 2 O 2 and H 2 O 2 + curcumin groups [40] . The media was refreshed after 30 min, added to the transwells, followed by an additional 24 h incubation. The cells were collected for subsequent experiments.
Transwell assay with LPS and curcumin
The transwell co-culture system with LPS and curcumin was designed as shown in Fig. 8A and 8B. Briefly, the BV2 cells were seeded into 24-well plates at a concentration of 1×10 4 cells per well, and the 661W cells were cultured into transwells at a concentration of 2×10 3 cells per well; the cells were separately cultured. After 17 h, the cells were divided into three groups: control, LPS-treated, and LPS + curcumin. Then, 20 µM/L curcumin was added to the BV2 cells of the LPS + curcumin group. The media was refreshed in each group after 3 h, and LPS (1 µg/mL) was added to the BV2 cells of the LPS and LPS + curcumin groups. The media was refreshed again after 4 h, followed by an additional incubation for 24 h, and subsequent collection of the cells for subsequent experiments.
Data processing and statistical analysis
Analysis of outer nuclear layer thickness. Data from three locations ranging from the posterior pole to the retinal margin (one close to the posterior pole, one submarginal, and another at the midpoint) in three retinal sections across the optic nerve from five rd1 mice and five C57 mice (n=5) were used for analysis with the Image J software (NIH, Bethesda, MD, USA). Each operation was performed in triplicate [43] . Cell counts. At least three frozen tissue sections from each mice and cell slides from each group (n=5) were used to perform the cell count. Apoptotic cells in the outer nuclear layer (ONL) on the cell slides, microglia in the retina sections, and proliferative cells in the cell slides were counted with the Image J software (NIH). To make the results more convincing, sections crossing the optic nerve were selected. All positive cells from the TUNEL assay and iba1 staining in the whole sections were counted rather than selected locations in sections. Positive cells in each cell slide were counted in at least three different locations [33] .
Quantitative assessment of ERG recordings. The graphs were processed by IGOR Pro 6.0.3.1 (WaveMetrics, Portland, OR, USA). The a-wave and b-wave amplitudes were analyzed by comparing the treated eyes with the contralateral eyes.
Calculation of time spent in light.The length of the time spent in the lit area was video-recorded and calculated using the following formula: (x/300) × 100%, where x = the time (s) in light. Four paws crossing the connecting door was defined as entering a chamber.
RNA expression analyses
RNA expression levels were analyzed using the 2 (-ΔΔCq) method with cyclophilin A as the control.
Statistical analysis
Data are presented as the mean ± standard deviation. Multiple comparisons were carried out by paired-samples t-test and independent sample t-test using SPSS 20.0 software (Chicago, IL, USA). P values less than 0.05 were considered statistically significant.
Results

Curcumin inhibited apoptosis of photoreceptors in the rd1 mice
Before studying the effects of curcumin on apoptosis in rd1 mice, we first analyzed the apoptotic status in C57 mice. There were few apoptotic cells in the retinas of C57 mice at P14 (Fig. 1A , B, A1, B1), and curcumin treatment did not influence this number (P>0.05; Fig. 1E ). In rd1 mice, the apoptosis of rod cells usually appears at P8 and peaks at P14 [29, 30] . In this study, the number of apoptotic cells in the ONL of DMSO-treated rd1 mice at P14 significantly increased compared with age-matched C57 mice (P<0.001; Fig. 1C, C1 , E). However, curcumin treatment significantly decreased this increase of apoptosis cells in the ONL (P<0.01; Fig. 1D , D1, E). In addition, there was no difference in ONL thickness between the C57 control mice and the curcumin-treated C57 mice (Fig. 1A, B, A1, B1, F) . However, the ONL thickness in DMSO-treated rd1 mice at P14 significantly decreased compared with the age-matched C57 mice (Fig. 1C, C1 ). Curcumin treatment significantly prevented the reduction of ONL thickness in rd1 mice at P14 (P<0.05; Fig. 1D, D1 F) .
Curcumin significantly improved the visual function of rd1 mice
In rd1 mice, the ERG response begins to reduce after eye opening, and becomes undetectable at around P21 [29] . In this study, we found that at P18, the normal ERG of C57 mice could be detected ( Fig. 2A, B) , and curcumin treatment did not affect the a-and b-wave amplitudes (a-wave: 84.7±24.60 and 53.1±26.56; b-wave: 215.4±80.39 and 153.7±40.89; P>0.05; Fig. 2E, F) . The ERGs of rd1 mice are nearly undetectable at low light intensity [29] . We found that DMSO-treated rd1 mice at P18 showed no amplitude of a-or b-waves (Fig.  2C, E, F) . However, curcumin treatment in rd1 mice recovered those waves at P18 (Fig. 2D) , especially for a-wave amplitudes (a-wave: 54.7±38.57; b-wave: 62.2±2.99; P a >0.05; P b <0.01; Fig. 2E, F) . To more generally assess the visual function, we conducted behavior tests in mice using the light/dark transition model. At P18, C57 mice had good light perception, and there was no difference between the DMSO-treated and curcumin-treated C57 mice (12.8±9.30% and 11.6±7.74% in light field, respectively; P>0.05). However, DMSO-treated rd1 mice at P18 showed no light perception (P<0.01), but curcumin treatment recovered the light perception (P<0.01). The curcumin-treated mice spent 14.4±10.56%, a similar time compared to C57 mice in the light field (P>0.05; Fig. 3B ). The results were consistent with the ERG results. the rd1 mice retina peaks at P14 [30] . In the present study, the microglia in the retinas of rd1 mice at P14 was activated and had the typical round and amoeboid-like shape. The microglia migrated from the inner nuclear layer to the ONL, where the photoreceptors degenerated and underwent apoptosis. The number of microglia in the retinas of rd1 mice at P14 treated with DMSO significantly increased compared with the age-matched untreated C57 mice (P<0.01; Fig. 4C , C1, E), and curcumin treatment significantly reduced this number of increased microglia (P<0.05; Fig. 4D, D1 , E). 
Curcumin regulated the expression levels of CCL2, TIMP-1, ET-1, and VCAM-1
After finding evidence of the immunomodulatory effects of curcumin, we were interested in determining the underlying mechanism. Thus, the expression of CCL2 in the retina was examined to study the effects of curcumin on chemokine secretion. The expression of CCL2 in the groups of C57 mice was low, and there was no significant difference between DMSOand curcumin-treated C57 mice. However, CCL2 expression significantly increased (P<0.01) at P14 in DMSO-treated rd1 mice compared with age-matched C57 mice. In addition, curcumin treatment significantly upregulated the expression of CCL2 even more at P14 in rd1 mice (P<0.01; Fig. 5A ). There was no significant difference in the expression level of ET-1 in the retina between DMSO-and curcumin-treated C57 or rd1 mice (P>0.05); however, its expression level was significantly decreased in the retina of rd1 mice at P14 compared with age-matched C57 mice (P<0.01; Fig. 5B ). For TIMP-1, there was no significant difference in expression level between DMSO-and curcumin-treated C57 mice (P>0.05), whereas the expression level in the retina of rd1 mice was significantly decreased (P<0.01). However, curcumin treatment significantly reversed the decreased expression level of TIMP-1 (P<0.005, Fig. 5C ). There was no significant difference in VACM-1 expression in the retina of DMSO-and curcumin-treated C57 mice (P>0.05), whereas the expression in DMSOtreated rd1 mice was significantly downregulated (P<0.01). However, curcumin treatment significantly reversed this decreased expression (P<0.05, Fig. 5D ).
Curcumin decreased the apoptosis of photoreceptors by inhibiting microglia proliferation in vitro
In this study, the proliferation of untreated BV2 cells was low (70.8±7.84%; Fig. 6A, A1) , and not influenced by curcumin or its solvent, DMSO (81.0±6.33% or 77.1±9.35%; P>0.05; Fig. 6B, C, B1, C1, G) . However, LPS treatment significantly increased the proliferation of BV2 
The high apoptosis rate of 661W cells increased the proliferation of BV2 cells, which could be inhibited by curcumin treatment
We used a transwell co-culture system to analyze the effects of apoptosis of 661W cells on the proliferation of BV2 cells and the function of curcumin (Fig. 7D, E) . The proliferation of BV2 cells co-cultured with untreated 661W cells was low (59.0±2.38; Fig. 7A, A1 ), but H 2 O 2 treatment of 661W cells significantly increased the proliferation of the co-cultured BV2 cells (75.9±4.25; P<0.001; Fig. 7B, B1, F) . On the other hand, curcumin treatment of BV2 cells significantly antagonized the increased proliferation (60.7±3.03; P<0.001; Fig. 7C, C1, F) . 
The high proliferation of BV2 cells increased the apoptosis of 661W cells, which was inhibited by curcumin
To further show the effects of curcumin, we used the transwell co-culture system to analyze the effects of BV2 proliferation on 661W cells and the function of curcumin (Fig. 8D,  E) . The apoptosis of 661W cells co-cultured with untreated BV2 cells was low (47.5±2.63%; Fig. 8A, A1 ), but LPS treatment of BV2 cells significantly increased apoptosis of the cocultured 661W cells (77.0±4.12%; P<0.001; Fig. 8B, B1, F) . On the other hand, curcumin treatment of BV2 cells significantly antagonized the increased apoptosis (36.1±5.70%; P<0.001; Fig. 8C, C1, F) .
Discussion
Curcumin has been well studied in neurodegenerative diseases such as Alzheimer's disease, in which it plays a role in epigenetics, modulating gene expression by changing environmental factors to cause a relative steady state. Its main effects on neurodegeneration diseases include anti-inflammation through the NF-κB pathway, anti-oxidant effects through the Nrf2 pathway, and disaggregation of polymers [44] [45] [46] [47] .
The present study showed that 7-day treatment of curcumin in rd1 mice significantly reduced the apoptosis of photoreceptor cells at P7, and protected the visual function of rd1 mice at P18. In addition, curcumin inhibited the activation of microglia and significantly regulated the expression of CCL2, VCAM-1, TIMP-1 in the retina of rd1 mice at P14. The underlying mechanism of its action appeared to be causing a decrease in photoreceptor apoptosis by suppressing the activation of microglia in vitro.
As a neurodegenerative disease, RP induces microglia activation [48] . Microglia cells, the first responders to cell damage within the retina, are involved in injury repair and inflammatory state [49] . Typically, activated microglia have two sources from which to play their respective roles: resident microglia tend of the M1 type mainly function in proinflammation and neurotoxin, whereas infiltrated bone marrow (BM)-derived monocytes tend to be of the M2 type with the main function of neuroprotection [3] . In the pathology of RP, the infiltration of BM-derived monocytes is restricted by the physiologic blood-retinal barrier (BRB), which causes neuroprotective function loss in the BM-derived monocytes, and may be the reason the damage in RP worsens rather than being repaired [3, 50] . CCL2, also called monocyte chemotactic protein 1, is usually secreted by microglia, nerve cells, and astrocytes, and bonds with the surface receptor CCR2 of inflammatory cells. The main function of CCL2 is to recruit microglia [51, 52] , especially BM-derived monocytes, to the site of injury through alerting the BRB [53, 54] . VCAM-1, another important endothelial-related molecule in chemotaxis, plays a role in the infiltration of BM-derived monocytes [10, 55] . TIMP-1, an inhibitor of MMPs, together with MMPs plays a role in alerting the BRB [11] . In the present study, the expression of these endothelial-related molecules significantly changed in rd1 mice, compared with age-matched C57 mice, which might have been the reason for the observed restriction of BM-derived monocyte infiltration. While, curcumin significantly changed the expression of CCL2, VCAM-1 and TIMP-1, it particularly reversed the low expression of VCAM-1 and TIMP-1. Thus, curcumin may be affective in facilitating BM-derived monocyte infiltration into the retina, thereby improving the state of the damaged retina. The in vitro results indicated that apoptosis of the photoreceptors promoted the activation of microglia, and in turn, activated microglia accelerated the apoptosis of photoreceptors. This vicious circle explains the progressive worsening of retinal injury observed in RP.
Immune cell-induced apoptosis is just one mechanism underlying apoptosis in RP; about 30% apoptosis is induced by increasing ATP levels [56] . According to our results, curcumin completely inhibited microglia activation in the retinas of rd1 mice, but did not inhibit the apoptosis of photoreceptors. These results suggest that there are other mechanisms that induce apoptosis, for example, an increase in ATP levels. Thus, the effects of curcumin on ATP should be addressed in further studies.
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
Curcumin treatment prevented complete loss of visual function in rd1 mice. In the P23H animal models, curcumin disrupted protein aggregates and decreased expression of endoplasmic reticulum stress markers in vitro [27, 28] . However, in rd1 mice, curcumin inhibited the activation of microglia and regulated the expression of immune-related factors in vivo. These differences reflected that the P23H mutant induced RP by abnormal protein aggregation and ER oxidant stress, but the PDE6β mutant induced RP by neuroinflammation. The effects of curcumin on RP were exactly the same as its main effects in neurodegenerative diseases. Thus, our results demonstrate the anti-inflammation effects of curcumin in neurodegenerative diseases.
According to our results, curcumin might only slow down the process of RP rather than reverse it, because it can inhibit the increasing number of microglia entirely, but cannot inhibit apoptosis. However, rod cells might secret some cytokines to protect cone cells [57] [58] [59] . So, delaying the process of rod cell degeneration is beneficial to both rod and cone cells.
Although the drug-delivery of curcumin is mostly gavage [25] , oral [60] , or by intraperitoneal injection [61] , and rarely by intravitreal injection [31] , we chose intravitreal injection to achieve the effective local concentration rapidly. In addition, intravitreal injection can be used to distinguish between the treated and untreated eye of a mouse [62] [63] [64] [65] [66] . Furthermore, using curcumin in utero might inhibit degeneration entirely [28] , given that it might be a better way to use curcumin prenatally for those who at high risk for RP. However, for patients who already have RP, it is possible that the earlier curcumin is taken, the better the effects that will result, although the condition will not be entirely reversed. To achieve local effective concentrations as soon as possible, intravitreal injections might be the best choice. Future studies on the dosage and frequency of curcumin treatment using intravitreal injection are needed.
Although curcumin can across blood brain barrier and BRB [27] , its poor solubility in water makes delivery a challenge. Maria designed a water-soluble complex of curcumin with cyclodextrins to make eyedrop delivery possible [67] . In addition, nanoparticles, which have been extensively studied in recent years, are being used as novel drug delivery systems because of their characteristics including biodegradability, non-toxicity, and hydrophilicity. In fact, Ayadi demonstrated that starch nanoparticles allowed curcumin to dissolve in water and undergo controlled release. In addition, Ayadi synthesized nanoparticles less than 10 nm in size to enable them to be excreted from the renal system and easily reach the necessary location [68] . Curcumin-loaded nanoparticles have already been used in several animal models of disease, especially cancer [68] [69] [70] [71] [72] [73] [74] .
Conclusion
As a multifunctional drug with anti-inflammation effects, curcumin protected photoreceptor cells by regulating microglia, resulting in the improved visual function of rd1 mice. Thus, curcumin may have therapeutic benefits in patients with RP.
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